Unlocking unique clinical research roadmaps using a systems approach When: Monday 15 September 2014, 12:45pm - 2:00pm Where: Room 218, The Melbourne Convention Centre Cost: Free “From Bench to Bedside” neatly captures the goal of translating basic medical research to clinical outcomes. However, the simplicity of this expression belies a world of complexity, from the initial discovery of clinical targets, to effective translation to therapies, and the numerous regulatory hurdles. But there are new roadmaps being forged using emerging systems biology platforms that offer researchers unique and sensitive navigation tools that can fast track the journey. Our panel of experts will present stateofart initiatives that showcase the future of this approach. Join us to hear their insights, and participate in a Q&A forum with the panel. Jonathan Fitzgerald, Ph.D. Vice President, Discovery, Merrimack Pharmaceuticals “Using Systems Biology Approaches to Guide Drug & Diagnostic Development” Maureen Turner Chief Executive Officer, BioGrid Australia Ltd., Australia “Realtime integration of federated genomic and clinical data making personalised medicine possible” Hiroaki Kitano, Ph.D. President, The Systems Biology Institute, and Principal Investigator, Laboratory for Disease Systems Modeling, RIKEN Center for Integrative Medical Sciences TBC This free event is part of the International Conference for Systems Biology: www.icsb14.com This Systems Biology Collaborative is part of the Enhancing Systems Biology In Victoria program, run by SBI Australia with support from the Victorian State Government.

Flyer for Drug Design Collaborative 15 Sep 14

Download PDF Report

Upload
hn
View
212
Download
0

Embed Size (px)

DESCRIPTION

Flyer for Drug Design Collaborative

Citation preview

Unlocking unique clinical research roadmaps using a systems approach

When: Monday 15 September 2014, 12:45pm - 2:00pm

Where: Room 218, The Melbourne Convention Centre

Cost: Free

“From Bench to Bedside” neatly captures the goal of translating basic medical research to clinical outcomes. However, the simplicity of this expression belies a world of complexity, from the initial discovery of clinical targets, to effective translation to therapies, and the numerous regulatory hurdles. But there are new roadmaps being forged using emerging systems biology platforms that offer researchers unique and sensitive navigation tools that can fast track the journey.

Our panel of experts will present state-‐of-‐art initiatives that showcase the future of this approach. Join us to hear their insights, and participate in a Q&A forum with the panel.

Jonathan Fitzgerald, Ph.D. Vice President, Discovery, Merrimack Pharmaceuticals “Using Systems Biology Approaches to Guide Drug & Diagnostic Development” Maureen Turner Chief Executive Officer, BioGrid Australia Ltd., Australia “Real-‐time integration of federated genomic and clinical data making personalised medicine possible” Hiroaki Kitano, Ph.D. President, The Systems Biology Institute, and Principal Investigator, Laboratory for Disease Systems Modeling, RIKEN Center for Integrative Medical Sciences TBC

This free event is part of the International Conference for Systems Biology: www.icsb14.com

This Systems Biology Collaborative is part of the Enhancing Systems Biology In Victoria program, run by SBI Australia with support from the Victorian State Government.